How Histopathologic Tumor Extent and Patterns of Recurrence Data Inform the Development of Radiation Therapy Treatment Volumes in Solid Malignancies☆
Introduction
The ability to effectively utilize radiation therapy (RT) depends critically on the availability of radiographic studies that can guide the delineation of the volumetric extent of disease. Advances in diagnostic imaging have allowed for improved delineation of the gross tumor extent, defined volumetrically as the gross tumor volume (GTV).Unfortunately, limitations still exist primarily in the inability to radiographically identify microscopic areas of disease that would not be identified with advanced imaging modalities. As a result, our knowledge of appropriate clinical tumor volume (CTV) margins has, in large, part been informed by surgical pathologic data as well as by analyzing patterns of recurrence and tumor spread. We aim to provide a comprehensive review of the current knowledge that informs modern day CTV margins for various solid malignancies.
Section snippets
High-Grade Glioma
There are currently 2 methods utilized in the contouring of high-grade gliomas (HGG): a single phase vs a 2-phase scheme. For example, the EORTC promotes a single-phase scheme where the GTV encompasses the T1-enhancing tumor mass and the resection cavity with a wide 3 cm margin for the CTV. Recently published guidelines from ESTRO-ACROP recommend a single CTV composed of the resection cavity and areas of T1-enhancement with a 2 cm margin.1 For secondary glioblastoma, they recommend the inclusion
Oral Tongue
Oral cavity cancer accounts for a large proportion of head and neck cancers overall, with a significant increase noted over the past 2 decades49 principally affecting young white females.50, 51 Lip and oral cavity tumors are predominantly managed with surgery, with the use of RT based on surgical, pathologic, and clinical risk factors. Given that oral tongue primaries represent the most common subsite in this cohort, our discussion will focus on CTV delineation for oral tongue cases.
Conventional Fractionated Radiotherapy
Definitive chemoradiotherapy (CRT) is generally indicated for locally advanced, stage IIIA-B disease but can also be utilized for stage II patients not eligible for surgery or stereotactic body radiation therapy (SBRT). Target volume delineation for NSCLC cases should be based on the information obtained from radiographic imaging studies such as CT chest or PET/CT scans, as well as from comprehensive mediastinal evaluations. In addition, 4-dimensional CT scans are regularly utilized for
Preoperative and Definitive
The role of preoperative or definitive RT in the management of esophageal carcinoma has been well established based on multiple randomized trials. Our current margin recommendations for CTV volumes derive primarily from clinical and pathologic series. Initially, the GTV for the gross primary should be delineated using diagnostic imaging and tumor extent as obtained from the EGD/EUS. For squamous cell histology, Gao et al142 prospectively analyzed the microscopic submucosal distance of spread
Definitive
With an estimated 161,000 new cases of prostate cancer (PC) in the U.S. in 2017, PC continues to remain the leading cancer diagnosis in males. RT is excellent management option for PC. Prospective trials have demonstrated the superiority of IMRT over 3-dimensional conformal (3D-CRT) techniques for the treatment of PC.173, 174 However, the advent of IMRT necessitated recommendations on appropriate target volume delineation. The recommended CTV volumes for PC vary depending on risk stratification
Pelvic Region
The CTV for whole-pelvic radiotherapy when treating locally advanced cervical cancer with definitive CRT includes the entire uterus with cervix, parametrial tissues including ovaries, entire mesorectum if uterosacral ligament is involved, upper vagina (longer length depending on degree of vaginal involvement), and regional nodes.203 Modern surgical series evaluating cervical cancer patients in whom positive lymph nodes were identified during radical abdominal hysterectomy or those undergoing
References (216)
- et al.
ESTRO-ACROP guideline target delineation of glioblastomas
Radiother Oncol
(2016) - et al.
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
Int J Radiat Oncol Biol Phys
(1989) - et al.
Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment
Int J Radiat Oncol Biol Phys
(1992) - et al.
Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post mortem topographic anatomy with CT correlations
Int J Radiat Oncol Biol Phys
(1989) - et al.
Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma
Int J Radiat Oncol Biol Phys
(2010) - et al.
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma
Int J Radiat Oncol Biol Phys
(2011) - et al.
Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms
Mayo Clin Proc
(1987) - et al.
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology evidence-based clinical practice guideline
Pract Radiat Oncol
(2016) - et al.
Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors
Rep Pract Oncol Radiother
(2012) - et al.
Low grade gliomas: Preliminary analysis of failure patterns among patients treated using 3D conformal external beam irradiation
Int J Radiat Oncol Biol Phys
(1995)
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: Preliminary results of Radiation Therapy Oncology Group 0424
Int J Radiat Oncol Biol Phys
Stereotactic radiotherapy for localized low-grade gliomas in children: Final results of a prospective trial
Int J Radiat Oncol Biol Phys
Medulloblastoma: Long-term results for patients treated with definitive radiation therapy during the computed tomography era
Int J Radiat Oncol Biol Phys
Patterns of failure following treatment for medulloblastoma: Is it necessary to treat the entire posterior fossa?
Int J Radiat Oncol Biol Phys
Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses
Int J Radiat Oncol Biol Phys
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma
Int J Radiat Oncol Biol Phys
Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas—Clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy
Int J Radiat Oncol Biol Phys
Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy
Int J Radiat Oncol Biol Phys
Radiosurgery for brain metastasis: Impact of CTV on local control
Radiother Oncol.
Radiosurgery with or without a 2-mm margin for 93 single brain metastases
Int J Radiat Oncol Biol Phys
A pathology-based substrate for target definition in radiosurgery of brain metastases
Int J Radiat Oncol Biol Phys
Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: Prospective evaluation of target margin on tumor control
Int J Radiat Oncol Biol Phys
Stereotactic radiation therapy for benign meningioma: Long-term outcome in 318 patients
Int J Radiat Oncol Biol Phys
Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT)
Radiother Oncol
Long-term efficacy of fractionated radiotherapy for benign meningiomas
Radiother Oncol.
Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011
Oral Oncol
Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT
Int J Radiat Oncol Biol Phys
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure
Oral Oncol.
Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: A retrospective analytic study in 315 patients
J Oral Maxillofac Surg
Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer
Int J Radiat Oncol Biol Phys
Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma
Int J Radiat Oncol Biol Phys
The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation
Pract Radiat Oncol
Re-evaluation of ipsilateral radiation for T1-T2N0-N2b tonsil carcinoma at the Princess Margaret Hospital in the human papillomavirus era, 25 years later
Int J Radiat Oncol Biol Phys
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial
Lancet Oncol.
High-risk factors of parotid lymph node metastasis in nasopharyngeal carcinoma: A case-control study
Radiat Oncol
Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI
Radiother Oncol.
Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets
Semin Radiat Oncol
Imaging of squamous cell carcinoma of the hypopharynx
Semin Ultrasound CT MR
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer
Radiother Oncol
RTOG chest wall contouring guidelines for post-mastectomy radiation therapy: Is it evidence-based?
Int J Radiat Oncol Biol Phys
Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy
Int J Radiat Oncol Biol Phys
ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1
Radiother Oncol.
Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume
Radiother Oncol
Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes
Radiother Oncol.
Variability of target and normal structure delineation for breast cancer radiotherapy: An RTOG multi-institutional and multiobserver study
Int J Radiat Oncol Biol Phys
A clinical perspective on regional nodal irradiation for breast cancer
Breast.
ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast
Int J Radiat Oncol Biol Phys
Mapping patterns of ipsilateral supraclavicular nodal metastases in breast cancer: Rethinking the clinical target volume for high-risk patients
Int J Radiat Oncol Biol Phys
Assumptions in the radiotherapy of glioblastoma
Neurology
Malignant astrocytomas: Focal tumor recurrence after focal external beam radiation therapy
J Neurosurg
Cited by (0)
- ☆
Conflict of interest: none.